FDA issued a Warning Letter to Sovereign Pharmaceuticals, LLC on 1/29/2013 for a previous inspection.
483 Sovereign Pharmaceuticals Jan 2018

483 Sovereign Pharmaceuticals Jan 2018

Patty Kaewussdangkul FDA$595.00 - Available Now

FDA investigators audited the Sovereign Pharmaceuticals - Fort Worth, TX, United States facility and issued inspectional observations (via FDA 483) on 12 Jan 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Jan 2018
  • Location: Fort Worth, United States
  • FEI: 3003229412
Add To Cart